Preservation of Ovarian Function After Hematopoietic Cell Transplant

PHASE2TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Multiple MyelomaNon-Hodgkin LymphomaHodgkin DiseaseAcute Myeloid LeukemiaMyeloproliferative Disorders
Interventions
DRUG

Leuprolide

Long-acting leuprolide 11.25 mg intramuscularly (IM) pre-transplant (HCT) and 3 months post-HCT PLUS Short-acting leuprolide 0.2 mg subcutaneously (SQ) daily for 14 days

BIOLOGICAL

hematopoietic cell transplant

Conventional bone marrow transplant regimen.

BIOLOGICAL

reduced intensity allogeneic HCT

A reduced-intensity conditioning transplant is a bone marrow or cord blood transplant (also called a BMT) that uses less intense treatment to prepare for transplant than a standard transplant does. While a standard transplant uses the pre-transplant treatment to destroy most of the disease cells, a reduced-intensity transplant relies on the donor's immune cells to fight disease.

Trial Locations (1)

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

Sponsors
All Listed Sponsors
collaborator

Minnesota Medical Foundation

OTHER

lead

Masonic Cancer Center, University of Minnesota

OTHER